GO
Loading...

Enter multiple symbols separated by commas

Merck & Co Inc

More

  • Pharmaceuticals Are Not Safe, Defensive Plays Tuesday, 10 Jun 2008 | 4:43 PM ET

    Everyone talking about Pfizer's spacer huge 7.1 percent dividend yield, which gets bigger every day because the stock keeps dropping. Is it safe?

  • What's Rampant Inflation Like? Look At Vietnam Tuesday, 10 Jun 2008 | 11:48 AM ET

    Vietnam effectively devalued its currency by 2 percent, according to the Asian Wall Street Journal, to bring official exchange rates closer to black market rates. Consumer prices rose 25 percent in May year over year. Vietnam has been raising rates recently to lower the inflation rate.

  • My ASCO Fiasco Tuesday, 3 Jun 2008 | 8:58 AM ET
    asco_new_logo.jpg

    This year, for the first time ever, ASCO agreed to let CNBC broadcast live from inside McCormick Place. It took years of reasoning, pleading, nagging and complaining to get inside. But finally, ASCO consented. In the past, the scientific organization has tried to keep more than an arm's distance from the financial media.

  • Sex and The the City

    You can get a steady diet of all things ASCO (American Society of Clinical Oncology) on CNBC and here at CNBC.com, so I'm gonna blog about something totally different. Well, it does have to do with cancer prevention. Specifically, staving off cervical cancer and/or the sexually transmitted disease known as HPV, which is the leading cause of cervical cancer.

  • Oil Drops 4% On Week Friday, 30 May 2008 | 6:16 PM ET
    graphic_word_ofthe_street.jpg

    Next week could be the biggest week for oil and other commodities in years, says Guy Adami. What's the "Word on the Street?"

  • Merck Wins Appeals in Three Vioxx Cases Thursday, 29 May 2008 | 10:57 AM ET
    vioxx_AP.jpg

    Appeals courts in New Jersey and Texas on Thursday scrapped verdicts against drug maker Merck stemming from some of the earliest trials involving its once popular painkiller Vioxx.

  • Test of Amgen D-mab Drug Confirms Earlier Results Wednesday, 28 May 2008 | 6:31 AM ET

    An experimental osteoporosis drug that is considered to be crucial to the future of biotechnology giant Amgen strengthened bones more than today's most widely-used treatment, research showed.

  • John McCain

    I'm thinkin' those two drug giants are champin' at the bit for the docs to get McCain off generic Zocor and onto Lipitor or Crestor. On recent conference calls, some PFE officials have said they think a lot of patients who've had a similar experience to McCain's will eventually come back around to Lipitor.

  • Oil, Inflation Worries Clamp Down on Stocks Tuesday, 20 May 2008 | 4:31 PM ET

    Stocks finished near session lows as oil prices soared and a measure of wholesale inflation surged, sparking worries that the Federal Reserve will start focusing on rising prices rather than slowing growth.

  • Oil, Inflation Worries Clamp Down on Stocks Tuesday, 20 May 2008 | 1:33 PM ET

    Stocks tumbled Tuesday as oil prices blew past $129 a barrel and a measure of wholesale inflation surged, sparking worries that the Federal Reserve will start focusing on rising prices rather than slowing growth.

  • chantix.jpg

    There's way too much stuff out of ASCO to do a comprehensive blog entry that would satisfy readers--especially small-cap biotechies. I mean, there are literally thousands of pages of research being published today by analysts on the new data.

  • Lightning Round: Merck, Whole Foods, Lowe's and More Thursday, 15 May 2008 | 6:32 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • Cramer’s Beating Himself Over Plough’s Shares Wednesday, 7 May 2008 | 6:43 PM ET

    The market can swing as much on sentiment as fact. Investors would be wise to remember this.

  • Your First Move For Wednesday May 7th Tuesday, 6 May 2008 | 6:44 PM ET
    graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Cisco, Disney Point to Higher Open Tuesday, 6 May 2008 | 6:14 PM ET
    graphic_word_ofthe_street.jpg

    A pair of crucial earnings "beats" capped off a day that defied expectations as the market ended higher despite having every reason to sell off. Find out what happened and how to trade it.

  • Optimism Fuels Stock Rally; Oil Tops $122 Tuesday, 6 May 2008 | 4:57 PM ET

    Stocks closed higher as optimism prevailed, even in the face of $122-a-barrel oil. Techs got a boost from speculation that a deal between Microsoft and Yahoo is still possible.

  • Energy, Tech Talk Fuel Market Rebound Tuesday, 6 May 2008 | 3:21 PM ET

    Stocks declined as oil surpassed $122 a barrel and Fannie Mae delivered disappointing results.

  • merck_logo.jpg

    After the closing bell yesterday, Merck announced that it plans to get rid of 12-hundred or around 15 percent of its sales reps. Like Schering-Plough, the company is having to adjust to lower sales of its Vytorin and Zetia cholesterol drugs and on top of that the Food and Drug...

  • Merck Plans to Reduce US Sales Force by 1,200 Monday, 5 May 2008 | 4:58 PM ET

    Merck, whose earnings have been hurt by patent expirations and declining sales of its Vytorin cholesterol fighter, said Monday it will eliminate another 1,200 members of its U.S. sales force as part of a restructuring begun in late 2005.

  • Not Having Enough Money Is Painful—Literally Thursday, 1 May 2008 | 6:38 PM ET

    Financial pain and physical pain may be linked: A new study says people who make less money and work in blue-collar jobs are more prone to be in pain.